SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0000950170-22-026695
Filing Date
2022-12-19
Accepted
2022-12-16 21:45:23
Documents
8
Effectiveness Date
2022-12-19

Document Format Files

Seq Description Document Type Size
1 S-8 srne_s-8_form.htm S-8 196371
2 EX-5.1 srne-ex5_1.htm EX-5.1 35149
3 EX-23.1 srne-ex23_1.htm EX-23.1 4751
4 EX-23.3 srne-ex23_3.htm EX-23.3 4996
5 EX-FILING FEES srne-exfiling_fees.htm EX-FILING FEES 36374
6 GRAPHIC img59730000_0.jpg GRAPHIC 15321
7 GRAPHIC img59730000_1.jpg GRAPHIC 25394
8 GRAPHIC img59730000_2.jpg GRAPHIC 15321
  Complete submission text file 0000950170-22-026695.txt   356326
Mailing Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121
Business Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121 858-203-4100
Sorrento Therapeutics, Inc. (Filer) CIK: 0000850261 (see all company filings)

IRS No.: 330344842 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-268861 | Film No.: 221469469
SIC: 2836 Biological Products, (No Diagnostic Substances)